Medication regimen complexity in cancer patients: an overlooked issue for healthcare team
In conclusion, integrating the MRCI into oncology practices, along with multidisciplinary care that includes clinical pharmacists, may enable the identification of high-risk patients, the individualization of drug treatment, and the optimization of the treatment process.
Authors
- Aygin Bayraktar‐Ekincioglu (ORCID: https://orcid.org/0000-0002-3481-0074)
- Ömer Dızdar (ORCID: https://orcid.org/0000-0003-0911-9078)
- Elif Aras‐Atik (ORCID: https://orcid.org/0000-0001-8667-6623)
- Sude Ayça Çifci (ORCID: https://orcid.org/0000-0002-0631-0056)
Institutions
- Hacettepe University (TR)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1007/s00520-025-09476-9
- Citations
- 3
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 3.67
Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Hacettepe Üniversitesi